These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 36359761)

  • 1. Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications.
    Zhang J; Zhang J; Zhang C; Zhang J; Gu L; Luo D; Qiu Q
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
    Urias EA; Urias GA; Monickaraj F; McGuire P; Das A
    Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-VEGF Therapy for Diabetic Eye Diseases.
    Bahrami B; Hong T; Gilles MC; Chang A
    Asia Pac J Ophthalmol (Phila); 2017; 6(6):535-545. PubMed ID: 29076303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
    Das A; McGuire PG; Rangasamy S
    Ophthalmology; 2015 Jul; 122(7):1375-94. PubMed ID: 25935789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current intravitreal pharmacologic therapies for diabetic macular edema.
    Colucciello M
    Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic macular edema.
    Lang GE
    Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Macular Edema: State of Art and Intraocular Pharmacological Approaches.
    Gurreri A; Pazzaglia A
    Adv Exp Med Biol; 2021; 1307():375-389. PubMed ID: 32488606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal dexamethasone insert in diabetic macular edema super-refractory to anti-vascular endothelial growth factor therapy.
    Wilkins CS; Sobol EK; Lema GM; Lee JG; Rosen RB; Deobhakta A
    Eur J Ophthalmol; 2022 Sep; 32(5):NP37-NP41. PubMed ID: 33757333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on current pharmacologic therapies for diabetic retinopathy.
    Muns SM; Villegas VM; Flynn HW; Schwartz SG
    Expert Opin Pharmacother; 2023; 24(14):1577-1593. PubMed ID: 37431888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-VEGF therapy for diabetic retinopathy].
    Chekhonin ES; Fayzrakhmanov RR; Sukhanova AV; Bosov ED
    Vestn Oftalmol; 2021; 137(4):136-142. PubMed ID: 34410069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema.
    Chauhan MZ; Rather PA; Samarah SM; Elhusseiny AM; Sallam AB
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.
    Desjardins DM; Yates PW; Dahrouj M; Liu Y; Crosson CE; Ablonczy Z
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2706-13. PubMed ID: 27191823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema.
    Moshfeghi DM; Kaiser PK; Michels S; Midena E; Kitchens JW; Prenner JL; Regillo CD; Reichel E
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6 Suppl):S4-S14. PubMed ID: 27348433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
    Brooks HL; Caballero S; Newell CK; Steinmetz RL; Watson D; Segal MS; Harrison JK; Scott EW; Grant MB
    Arch Ophthalmol; 2004 Dec; 122(12):1801-7. PubMed ID: 15596583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-VEGF therapy for diabetic macular edema.
    Stewart MW
    Curr Diab Rep; 2014 Aug; 14(8):510. PubMed ID: 24919750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
    Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
    Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metformin treatment with enhanced effect of anti-VEGF agents in diabetic macular edema patients.
    Shao Y; Wang M; Zhu Y; Li X; Liu J
    Acta Diabetol; 2022 Apr; 59(4):553-559. PubMed ID: 35034186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing treatment for diabetic macular edema during cataract surgery.
    Chan LKY; Lin SS; Chan F; Ng DS
    Front Endocrinol (Lausanne); 2023; 14():1106706. PubMed ID: 36761187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Murata T
    Retina; 2018 Sep; 38(9):1801-1808. PubMed ID: 29280940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choice of treatment for diabetic macular edema].
    Yang L; Zhang J
    Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):724-728. PubMed ID: 29050184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.